Aromasin has been used for a long time to fight E2 related breast cancer but what really caught my eye was the comment on the patent expiring. Very good news for us!
"The drug is sold by Pfizer Inc under the brand name Aromasin, which lost its patent April 1, 2011 and is now available in a cheaper generic version."
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.